Increased risks for random errors are common in outcomes graded as high certainty of evidence.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
02 2019
Historique:
received: 07 01 2018
revised: 20 08 2018
accepted: 10 10 2018
pubmed: 22 10 2018
medline: 18 1 2020
entrez: 22 10 2018
Statut: ppublish

Résumé

The aim of article was to assess the risk for random errors in outcomes graded as high certainty of evidence (CoE). We randomly selected 100 Cochrane reviews with dichotomous outcomes rated as high CoE using Grading of Recommendations Assessment, Development, and Evaluation. To detect increased risks for random errors, two investigators independently conducted trial sequential analysis using conventional thresholds for type I (α = 0.05) and type II (β = 0.10) errors. We dually regraded all outcomes with increased risks for random errors and conducted multivariate logistic regression analyses to determine predictors of increased risks for random errors. Overall, 38% (95% confidence interval: 28-47%) of high CoE outcomes had increased risks for random errors. Outcomes assessing harms were more frequently affected than outcomes assessing benefits (47% vs. 12%). Regrading of outcomes with increased random errors showed that 74% should have been downgraded based on current guidance. Regression analyses rendered small absolute risk differences (P = 0.009) and low number of events (P = 0.001) as significant predictors of increased risks for random errors. Decisionmakers need to be aware that outcomes rated as high CoE often have increased risks for false-positive or false-negative findings.

Identifiants

pubmed: 30342970
pii: S0895-4356(18)30008-8
doi: 10.1016/j.jclinepi.2018.10.009
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-59

Subventions

Organisme : AHRQ HHS
ID : R03 HS024749
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Gerald Gartlehner (G)

RTI International, Research Triangle Park, NC, USA; Cochrane Austria, Danube University Krems, Krems, Austria. Electronic address: ggartlehner@rti.org.

Barbara Nussbaumer-Streit (B)

Cochrane Austria, Danube University Krems, Krems, Austria.

Gernot Wagner (G)

Cochrane Austria, Danube University Krems, Krems, Austria.

Sheila Patel (S)

RTI International, Research Triangle Park, NC, USA.

Tammeka Swinson-Evans (T)

RTI International, Research Triangle Park, NC, USA.

Andreea Dobrescu (A)

Genetics Department, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

Christian Gluud (C)

Copenhagen Trial Unit; Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH